Accuray Incorporated Stock Alpha and Beta Analysis
| ARAY Stock | USD 2.03 0.10 5.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Accuray Incorporated. It also helps investors analyze the systematic and unsystematic risks associated with investing in Accuray Incorporated over a specified time horizon. Remember, high Accuray Incorporated's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Accuray Incorporated's market risk premium analysis include:
Beta 1.99 | Alpha (0.41) | Risk 4.15 | Sharpe Ratio (0.01) | Expected Return (0.06) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Accuray |
Accuray Incorporated Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Accuray Incorporated market risk premium is the additional return an investor will receive from holding Accuray Incorporated long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Accuray Incorporated. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Accuray Incorporated's performance over market.| α | -0.41 | β | 1.99 |
Accuray Incorporated expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Accuray Incorporated's Buy-and-hold return. Our buy-and-hold chart shows how Accuray Incorporated performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Accuray Incorporated Market Price Analysis
Market price analysis indicators help investors to evaluate how Accuray Incorporated stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Accuray Incorporated shares will generate the highest return on investment. By understating and applying Accuray Incorporated stock market price indicators, traders can identify Accuray Incorporated position entry and exit signals to maximize returns.
Accuray Incorporated Return and Market Media
The median price of Accuray Incorporated for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 1.88 with a coefficient of variation of 8.74. The daily time series for the period is distributed with a sample standard deviation of 0.17, arithmetic mean of 1.91, and mean deviation of 0.13. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 8404 shares by Ali Pervaiz of Accuray Incorporated at 2.0557 subject to Rule 16b-3 | 09/04/2024 |
2 | Accuray CFO sells over 17k in company stock - Investing.com | 09/06/2024 |
3 | Acquisition by Patrick Spine of 88580 shares of Accuray Incorporated subject to Rule 16b-3 | 09/11/2024 |
4 | Acquisition by Nishimura Mika of 59055 shares of Accuray Incorporated subject to Rule 16b-3 | 10/09/2024 |
5 | Heres Why You Should Retain Accuray Stock in Your Portfolio Now | 10/17/2024 |
6 | Disposition of 3305 shares by Ali Pervaiz of Accuray Incorporated at 2.0097 subject to Rule 16b-3 | 10/18/2024 |
7 | Radiosurgery and Radiotherapy Robotics Market to grow by USD 713.4 Million from 2024-2028, driven by rising cancer cases and retreatments, with AI driving marke... | 10/21/2024 |
8 | Disposition of 26799 shares by Sandeep Chalke of Accuray Incorporated at 1.702 subject to Rule 16b-3 | 10/25/2024 |
9 | Disposition of 3207 shares by Ali Pervaiz of Accuray Incorporated at 1.86 subject to Rule 16b-3 | 10/29/2024 |
10 | Accuray earnings beat by 0.01, revenue topped estimates | 11/06/2024 |
11 | Accuray Inc Q1 2025 Earnings Call Highlights Navigating Challenges with Strategic ... | 11/07/2024 |
12 | Accuray Incorporated Q1 2025 Earnings Call Transcript | 11/08/2024 |
13 | Merit Medical Stock Gains 37.9 percent Year to Date Whats Behind the Rally | 11/20/2024 |
About Accuray Incorporated Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Accuray or other stocks. Alpha measures the amount that position in Accuray Incorporated has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 80.18 | 60.98 | 75.2 | 56.0 | PTB Ratio | 3.39 | 6.84 | 3.84 | 1.94 |
Accuray Incorporated Upcoming Company Events
As portrayed in its financial statements, the presentation of Accuray Incorporated's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accuray Incorporated's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Accuray Incorporated's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Accuray Incorporated. Please utilize our Beneish M Score to check the likelihood of Accuray Incorporated's management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of August 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Build Portfolio with Accuray Incorporated
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.